Related Experiment Videos

Clinical and laboratory findings at initial diagnosis in pediatric Graves' disease in Taiwan

Chia-Sui Hung1, Luan-Yin Chang, Hsun-Hui Sui

  • 1Division of Pediatric Endocrinology & Metabolism, Department of Pediatrics, Chang Gung Memorial Hospital and Chang Gung Children's Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.

Acta Paediatrica Taiwanica = Taiwan Er Ke Yi Xue Hui Za Zhi
|August 25, 2006
PubMed

Insights

Pediatric Graves' disease presentation is similar across prepubertal, pubertal, and postpubertal stages. Early diagnosis is crucial as this thyroid disorder impacts children's growth and development.

Area of Science:

  • Pediatric Endocrinology
  • Autoimmune Diseases
  • Thyroid Disorders

Background:

  • Graves' disease is the most common cause of hyperthyroidism in children.
  • Understanding disease presentation across different pubertal stages is essential for timely diagnosis and management.

Purpose of the Study:

  • To analyze the clinical and laboratory characteristics of pediatric Graves' disease based on pubertal status.
  • To identify differences or similarities in disease presentation among prepubertal, pubertal, and postpubertal children.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 106 children with newly diagnosed Graves' disease (1995-2005).
  • Patients were categorized into prepubertal, pubertal, and postpubertal groups based on Tanner stages.
  • Comparison of clinical symptoms, physical findings, and laboratory results across the three groups.

Main Results:

  • No significant differences in clinical presentation or laboratory findings were observed among the prepubertal, pubertal, and postpubertal groups.
  • Common symptoms included goiter, heat intolerance, palpitations, and weight loss.
  • Frequent physical findings were tachycardia, goiter, tremor, and exophthalmos.
  • Elevated free thyroxine (FT4), total thyroxine (TT4), and total triiodothyronine (TT3) with suppressed thyroid-stimulating hormone (TSH) were consistent across groups.
  • High prevalences of thyroid-binding immunoglobulin (TBII), anti-microsomal antibodies (AMCA), and thyroglobulin antibodies (TGAB) were noted.

Conclusions:

  • The presentation of Graves' disease in children is consistent regardless of pubertal stage.
  • Prompt recognition of symptoms is vital for effective management to prevent adverse effects on growth and development.
  • Graves' disease can significantly impact a child's overall growth and development if not managed promptly.

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...